AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Corvus Pharmaceuticals, Inc. Director's Dealing 2025

Apr 9, 2025

32755_dirs_2025-04-09_66d3ca72-df7d-4d4a-ab1a-45454e6f7c10.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2025-04-08

Reporting Person: van den Broek Richard (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	160000	Indirect

Footnotes

F1: Shares held by HSMR Advisors, LLC, of which the Reporting Person is the sole owner.